Author

P. M. K. Westcott

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Balmain· 1 shared A. Bhutkar· 1 shared A. Jin· 1 shared A. M. Cruz· 1 shared A. M. Jaeger· 1 shared D. A. Canner· 1 shared D. Zhang· 1 shared F. Muyas· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Balmain

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 24, 2021

Mismatch repair deficiency is not sufficient to increase tumor immunogenicity

P. M. K. Westcott, F. Muyas, O. Smith…·T. Jacks

This study shows that MMRd in mouse tumor models does not increase immunogenicity or ICB response, due to intratumoral heterogeneity.

DOI 10.1101/2021.08.24.457572

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 22, 2019

Regulation of KRAS4A/B splicing in cancer stem cells by the RBM39 splicing complex.

W.-C. Chen, M. D. To, P. M. K. Westcott…·A. Balmain

This study identifies KRAS4A and KRAS4B splice isoforms with distinct expression patterns in cancer stem cells and shows that targeting KRAS4A splicing is a potential therapeutic strategy in KRAS mutant tumors.

DOI 10.1101/646125

mousebulk RNA-seq

𝕏 PostBluesky